Scientists dive deep into mesothelioma tumors to unlock new treatment clues

NCT ID NCT06581549

Recruiting now Knowledge-focused Sponsor: Istituto Oncologico Veneto IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is looking at tumor samples from 220 people with pleural or peritoneal mesothelioma, a rare cancer linked to asbestos. Researchers will analyze the genes and immune cells in these tumors to find patterns that could predict which treatments work best. The goal is to improve personalized medicine for this hard-to-treat cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could identify new drug targets and better ways to match treatments to individual mesothelioma patients.
What could go wrong: This is an observational study analyzing existing samples, not testing a new treatment directly. Results may not lead to immediate therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MESOTHELIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pleural mesothelioma mesothelioma Mesothelioma, Malignant peritoneal mesothelioma pleural mesothelioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MESOTHELIOMA MESOTHELIOMA; LUNG MESOTHELIOMAS PLEURAL

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Asst Grande Ospedale Metropolitano Niguarda-Milano
RECRUITING

Milan, Italy
Asst Papa Giovanni Xxiii Bergamo
RECRUITING

Bergamo, Italy
Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo
RECRUITING

Alessandria, 15121, Italy
Azienda Ospedaliera Universitaria Integrata Verona
RECRUITING

Verona, Italy
Azienda Ospedaliera-Universitaria di Parma
RECRUITING

Parma, 43126, Italy
Centro di Riferimento Oncologico (CRO) IRCCS
RECRUITING

Aviano, Pordenone, 33081, Italy
Fondazione Ircss Istituto Nazionale Dei Tumori Di Milano
RECRUITING

Milan, Italy
Ircss Ospedale Policlinico San Martino
RECRUITING

Genova, Italy
Istituto Clinico Humanitas
RECRUITING

Rozzano, Milano, 20089, Italy
Istituto Oncologico Veneto
RECRUITING

Padova, 35128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.